Fund comparison · from official SEC filings

FHLC vs VGHCX: how much do they overlap?

Fidelity MSCI Health Care Index ETF and VANGUARD HEALTH CARE FUND
Holdings overlap
49%
of assets, by weight
Shared positions
61
of 338 / 98 holdings
FHLC expense ratio
0.08%
net, per year
VGHCX expense ratio
0.33%
net, per year
Shared holdings
Company
FHLC
VGHCX
L
LLYELI LILLY & CO
12.15%
9.11%
J
JNJJOHNSON & JOHNSON
8.96%
3.46%
A
ABBVABBVIE INC
6.04%
1.35%
M
MRKMERCK & CO. INC.
4.38%
5.43%
U
UNHUNITEDHEALTH GROUP INC
5.43%
3.93%
E
EWEDWARDS LIFESCIENCES CORP
0.78%
3.22%
T
TMOTHERMO FISHER SCIENTIFIC INC
2.91%
0.97%
I
ISRGINTUITIVE SURGICAL INC
2.62%
2.72%
A
ABTABBOTT LABORATORIES
2.55%
2.18%
B
BSXBOSTON SCIENTIFIC CORP
1.38%
2.36%
D
DHRDANAHER CORP
1.84%
2.35%
C
CVSCVS HEALTH CORP
1.71%
2.21%
V
VRTXVERTEX PHARMACEUTICALS INC
1.75%
2.10%
C
CORCENCORA INC
0.92%
2.08%
B
BMYBRISTOL-MYERS SQUIBB CO
1.99%
0.60%
E
ELVELEVANCE HEALTH INC
1.35%
1.90%
R
REGNREGENERON PHARMACEUTICALS
1.18%
1.79%
S
SYKSTRYKER CORP
1.75%
0.83%
M
MDTMEDTRONIC PLC
1.68%
0.93%
H
HCAHCA HEALTHCARE INC
1.12%
1.42%
A
ALNYALNYLAM PHARMACEUTICALS INC
0.66%
1.41%
B
BIIBBIOGEN INC
0.45%
1.30%
U
UTHRUNITED THERAPEUTICS CORP
0.38%
1.28%
C
CAHCARDINAL HEALTH INC
0.74%
1.22%
A
AAGILENT TECHNOLOGIES INC
0.53%
1.20%
Only in FHLC
A
AMGNAMGEN INC
3.02%
G
GILDGILEAD SCIENCES INC
2.63%
P
PFEPFIZER INC
2.45%
M
MCKMCKESSON CORP
1.63%
C
CITHE CIGNA GROUP
1.26%
Z
ZTSZOETIS INC
0.82%
I
IDXXIDEXX LABORATORIES INC
0.72%
B
BDXBECTON DICKINSON AND CO
0.69%
R
RMDRESMED INC
0.50%
W
WATWATERS CORP
0.49%
I
INSMINSMED INC
0.47%
H
HUMHUMANA INC
0.46%
G
GEHCGE HEALTHCARE TECHNOLOGY
0.45%
I
IQVIQVIA HOLDINGS INC
0.44%
M
MTDMETTLER-TOLEDO INTERNATIONAL
0.42%
V
VEEVVEEVA SYSTEMS INC-CLASS A
0.39%
D
DGXQUEST DIAGNOSTICS INC
0.35%
W
WSTWEST PHARMACEUTICAL SERVICES
0.35%
L
LHLABCORP HOLDINGS INC
0.34%
R
RPRXROYALTY PHARMA PLC- CL A
0.33%
I
ILMNILLUMINA INC
0.31%
V
VTRSVIATRIS INC
0.28%
Z
ZBHZIMMER BIOMET HOLDINGS INC
0.26%
T
THCTENET HEALTHCARE CORP
0.25%
T
TPIXXSTATE ST INST TR PL MM-PREM
0.23%
Only in VGHCX
A
AZNASTRAZENECA PLC
5.11%
G
GLAXFGSK PLC
3.14%
A
ARGNFARGENX SE
2.21%
U
UCBJFUCB SA
1.74%
N
NVSEFNOVARTIS AG-REG
1.63%
G
GDERFGALDERMA GROUP AG
1.27%
C
CHGCFCHUGAI PHARMACEUTICAL CO LTD
1.25%
R
RHHVFROCHE HOLDING AG
1.24%
O
OTSKFOTSUKA HOLDINGS CO LTD
1.23%
S
SGIOFSHIONOGI & CO LTD
1.12%
D
DSKYFDAIICHI SANKYO CO LTD
1.00%
G
GNMSFGENMAB A/S
0.97%
A
ASNDASCENDIS PHARMA A/S
0.66%
Q
QGENQIAGEN N.V.
0.61%
E
ESALFEISAI CO LTD
0.60%
I
ICLRICON PLC
0.50%
N
NONOFNOVO NORDISK A/S-B
0.48%
G
GPCRSTRUCTURE THERAPEUTICS INC
0.33%
I
IMCRIMMUNOCORE HOLDINGS PLC-ADR
0.32%
2
2595GENFLEET THERAPEUTICS SHAN-H
0.28%
D
DUTBFDUALITY BIOTHERAPEUTICS INC
0.27%
?
Bank of America Securities, LLC
0.26%
M
MTHRFM3 INC
0.25%
?
HSBC Bank USA
0.24%
J
JNGHFJIANGNAN GROUP LTD
0.23%
Hold FHLC and VGHCX together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.